NPCE Q3 2025 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$27M+29.9% YoY

Gross Profit

$21M77.4% margin

Operating Income

-$3M-9.5% margin

Net Income

-$3M-12.8% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+16.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$107M

Total Liabilities

$89M

Stockholders' Equity

$19M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$21M	+29.9%
Gross Profit	$21M	$15M	+37.3%
Operating Income	-$3M	-$4M	+38.7%
Net Income	-$3M	-$5M	+35.9%